Dr. Brian Lian's holdings in Viking Therapeutics have seen significant ups and downs. In early 2024, his holdings peaked at an impressive $84.52 million, indicating his strong financial commitment to the company's future. Earlier trades were substantial as well, starting...

$117.50M192.45%

Nov 15, 2024

Stock Sold

$51.60M

VKTX

$51.60M

1,437,626 shares

What if they kept their stock?

If Brian Lian, Ph.D. didn't sell their stock, today they would have:
Extra VKTX1,437,626 shares worth $71.28M.
This is 38.14% and $19.68M more than what they got when they sold the stock.
If they kept all their stock, their total holdings would be worth $188.78M.

Recent Insider Trades

VKTX

$15.39M

VKTX at $71.19/share

Sep 20, 2024

Sale

VKTX

$69.90K

VKTX at $69.90/share

Aug 21, 2024

Sale

VKTX

$7.48M

VKTX at $66.27/share

Aug 19, 2024

Sale

VKTX

$6.70M

VKTX at $57.85/share

Jul 29, 2024

Sale

VKTX

204,333 shares

VKTX

Jul 29, 2024

Received

VKTX

221,667 shares

VKTX

Mar 27, 2024

Received

VKTX

221,667 shares

VKTX

Mar 1, 2024

Received

VKTX

$1.35M

VKTX at $29.90/share

Feb 9, 2024

Sale

VKTX

$7.27M

VKTX at $27.00/share

Feb 8, 2024

Sale

VKTX

$2.10M

VKTX at $24.70/share

Jan 31, 2024

Sale

Brian Lian, Ph.D.

CEO of Viking Therapeutics

V

View Compensation History

2023 Total Compensation

$5.95M

Salary

$615.00K

Bonus

$372.10K

Stock

$4.96M

Other

$0.00